PSMB8 (LMP7) but not PSMB9 (LMP2) gene polymorphisms are associated to pigeon breeder's hypersensitivity pneumonitis  by Camarena, Ángel et al.
Respiratory Medicine (2010) 104, 889e894ava i lab le at www.sc ienced i rec t . com
journa l homepage : www.e lsev ier . com/ loca te / rmedPSMB8 (LMP7) but not PSMB9 (LMP2) gene
polymorphisms are associated to pigeon breeder’s
hypersensitivity pneumonitisA´ngel Camarena a, Arnoldo Aquino-Galvez a, Ramce´s Falfa´n-Valencia a,
Gloria Sa´nchez a, Martha Montan˜o a, Carlos Ramos a, Armida Jua´rez a,
Carolina Garcı´a-de-Alba a, Julio Granados b, Moise´s Selman a,*a Instituto Nacional de Enfermedades Respiratorias ‘‘Ismael Cosio Villegas’’, Tlalpan 4502, Seccio´n XVI, CP 14080,
Me´xico City, DF, Mexico
b Instituto Nacional de Ciencias Me´dicas y Nutricio´n ‘‘Salvador Zubira´n’’, Vasco de Quiroga 15, Seccio´n XVI,
14080 Me´xico City, Mexico
Received 20 November 2009; accepted 20 January 2010
Available online 11 February 2010KEYWORDS
Hypersensitivity
pneumonitis;
PSMB9;
LMP2;
PSMB8;
LMP7* Corresponding author. Tel.: þ52 55
E-mail address: mselmanl@yahoo.
0954-6111/$ - see front matter ª 201
doi:10.1016/j.rmed.2010.01.014Summary
Hypersensitivity Pneumonitis (HP) is a lung inflammatory disorder caused by inhalation of
organic particles by a susceptible host. However, only a small proportion of individuals
exposed to HP-associated antigens develop the disease, suggesting that additional host/
environmental factors may play a role. We have previously found that genetic susceptibility
associated to the major histocompatibility complex (MHC) plays an important role in this
disease. The low molecular weight proteosome (LMP, currently named PSMB) genes code
for subunits of the proteosome, a multimeric enzymatic complex that degrades proteins
into peptides in order to be presented in the MHC class I pathway. We hypothesized that
polymorphisms in PSMB8 or PSMB9 genes could be involved in the susceptibility to HP. Thus,
in this study we analyzed the polymorphic site at amino acid position 60 (Arg/His) of the
fourth exon in the PSMB9 gene and the amino acid position 49 (Gln/Lys) in the second exon
of PSMB8 gene in 50 Mexican patients with HP and 50 healthy ethnically matched controls.
PSMB typing was performed using polymerase chain reaction-restriction fragment length
polymorphisms (PCR-RFLP). Our results demonstrated that HP patients had a significant
increase of the PSMB8 KQ genotype frequency (OR Z 7.25, CI Z 2.61e 21.3;
p Z 0.000034). No differences were found in the distribution of PSMB9 alleles/genotypes.5487 1771; fax: þ52 55 5665 4623.
com.mx (M. Selman).
0 Elsevier Ltd. All rights reserved.
890 A´. Camarena et al.Table 1 Actual and previous no
Gene name
HGNC Previous
PSMB9 LMP2
PSMB8 LMP7
HGNC: HUGO Gene Nomenclature CHowever, PSMB9-RH/PSMB8 KQ haplotype was significantly increased in HP patients
(OR Z 6.77, CI Z 1.34e65.31, p < 0.02). These findings suggest that PSMB8 KQ genotype
could increase the risk to develop hypersensitivity pneumonitis.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
Hypersensitivity pneumonitis (HP) is an immunologically
mediated lung disease caused by repeated inhalation of
a wide variety of antigens in susceptible individuals.1
Pigeon breeder’s disease, one of the most common forms
of HP, is provoked by exposure to various avian-derived
antigens. The clinical presentation is heterogeneous and
the individuals exposed to low levels of avian antigens, can
develop sub-acute or chronic forms of the disease and some
of them may evolve to pulmonary fibrosis.2 Importantly,
only a small proportion of exposed individuals develop the
disease indicating that susceptibility involves genetic or
other environmental factors.2,3 We have previously identi-
fied some haplotypes of the major histocompatibility
complex (MHC) class II and polymorphisms in the trans-
porter associated with antigen processing (TAP) genes
associated with increased risk to develop HP.4,5
The antigen processing machinery is the combination
of the cellular processes responsible for the presentation
of endogenous peptides by HLA class I molecules. These
peptides are generated by specialized immunoprotea-
somes composed of LMP2, LMP7 and LMP10 subunits.6,7
The LMP2 and LMP7 genes are located within the class
II region, and encode two subunits of the proteasome
complex involved in the degradation of cytosolic proteins
and the generation of antigenic peptides.8e10 Recently,
the Human Genome Organization (HUGO) Gene nomen-
clature committee and the HLA informatics group estab-
lished the actual name for LMP2 as PSMB9 (Proteasome
[prosome, macropain] subunit, beta type, 9 [large
multifunctional peptidase 2]) and for LMP7 as PSMB8
(Proteasome [prosome, macropain] subunit, beta type, 8
[large multifunctional peptidase 7]).11,12 The analysis of
these gene polymorphisms have been typically performed
by using codon positions (LMP2 Arg60His and LMP7
Gln49Lys); however, this nomenclature makes difficult the
comparison of alleles and genotypes frequencies in
international databases. We use ‘‘rs number’’ for evalu-
ation and comparison of our results (Table 1 summarizes
the previous and current nomenclature).
The aim of this study was to investigate whether poly-
morphisms in PSMB8 and PSM9 genes are involved in the
susceptibility to hypersensitivity pneumonitis.menclature of PSMB9 and PSMB
Polymorphisms
Exon Codon
4 CGC/ CAC
2 CAG/ AAG
ommittee (11).Material and methods
Study population
Fifty unrelated patients with diagnosis of HP provoked by
avian antigens (pigeon breeder’s disease, 10 males and 40
females) were included in this study. Diagnosis of HP was
established as described elsewhere.3,13 Briefly, all patients
had home exposure to birds and positive serum antibodies
against avian antigens determined by ELISA. Chest high-
resolution computed tomography scanning showed diffuse
centrilobular poorly defined micronodules, ground glass
attenuation, focal air trapping and mild/moderate fibrotic
changes, and the bronchoalveolar lavage displayed >40%
lymphocytes. Forty-fivepercent of the patientswere biopsied
and histopathological abnormalities confirmed the diagnosis
of HP. The control group (34males, 16 females)was composed
by fifty ethnically matched unrelated healthy Mexican bird-
exposed but asymptomatic subjects (EAS), without history of
collagen-vascular disorders, diabetes or other autoimmune or
chronic-degenerative disease. Patients and controls had at
least two generations that were born in Mexico, and thus
considered to be Mexican Mestizo.14,15 The protocol was
approved by the Scientific and Bioethic Committee and
patients and controls signed an informed consent letter.
Genomic DNA extraction
Genomic DNA was extracted from peripheral blood using
a BDtract genomic DNA isolation kit (Maxim Biotech, San
Francisco CA).
Amplification of genomic DNA
To obtain the sequences that include the polymorphic sites,
we designed two pairs of primers: (50-GCC AGC AAG AGC
CGA AAC AAG-30, 50-GTG AAC CGA GTG TTT GAC AAG C-30)
for PSMB9 and (50-CGG ACA GAT CTC TGG GTG CT-30, 50-TCT
CCG GGA CTG AAG GCT A-30) for PSMB8. All PCR amplifi-
cations were performed on 40 ng of genomic DNA in a 25 mL
reaction volume containing 50 mM KCl, 10 mM Tris-Cl, pH
8.3, 1.5 mM MgCl; 200 uM of each dNTP’s and 20 pmol of
each primer. Samples were subjected to 1 hold 96 C 5 min8 polymorphisms.
Residue Change Position SNP
R (Arg)/ H (His) 60 rs17587
Q (Gln)/ K (Lys) 49 rs2071543
Table 2 Allele frequencies of PSMB9 and PSMB8.
Allele HP patients
n Z 50
EAS group
n Z 50
p Value OR (CI 95%)
n af N af
PSMB9
R 68 0.68 65 0.65 0.764 1.14 (0.61e2.15)
H 32 0.32 35 0.35 0.764 0.87 (0.46e1.64)
PSMB8
Q 53 0.53 80 0.80 0.000098 0.28 (0.14e0.55)
K 47 0.47 20 0.20 0.000098 3.55 (1.82e7.03)
HP: hypersensitivity pneumonitis; EAS: exposed asymptomatic subjects; OR: Odds ratio, CI: confidence interval, af: allele frequency.
PSMB polymorphisms and HP 891and then linked to 94 C 60 s, 64 C 60 s and 72 C 30 s, 30
cycles for PSMB8, and 94 C 60 s, 60 C 60 s and 72 C 60 s,
25 cycles for PSMB9; this cycling was followed by a final
extension at 72 C for 7 min, using an automated thermal
cycler (GeneAmp PCR system 9700, PE Applied Biosystems.
Foster City CA). Amplifications were performed using Plat-
inum Taq DNA polymerase (Invitrogen, Brazil). Amplifica-
tion PCR products were electrophoresed in submarine 2%
agarose gels containing 0.2 mg/mL ethidium bromide for
40 min (30 V/cm) and the amplified bands were visualized
in a dual intensity UV light trans-illuminator (UVP Inc.
Upland, CA), and finally analyzed and stored in EDAS290
photodocumentation system (Kodak, Rochester NY).Restriction of amplified products
The polymorphic site at amino acid position 60 (Arg/His) of
the fourth exon in the PSMB9 gene and the amino acid posi-
tion 49 (Gln/Lys) in the second exon of PSMB8 gene, were
analyzed by Restriction Fragment Length Polymorphism
(RFLP) method. The PCR products 252 for PSMB9 and 304 for
PSMB8 were digested with 7 U Cf01 and 4 U Bsm1 (New
England Biolabs, Beverly, MA) respectively, at 37 C for 4 h.
Since Cf01 recognizes the polymorphic site for PSMB9, the H
(His) allele was demonstrated by the presence of two frag-
ments (210 and42bp)whereas theR (Arg) allelewas revealed
by the presence of a single 252 bp band. Alleles of PSMB8
were defined by Bsm1, where Q (Gln) had two bands of 174
and 130 bp, and K (Lys) a single 304 bp band. The obtainedTable 3 Genotype frequencies of PSMB9 and PSMB8.
Genotype HP patients
n Z 50
EAS group
n Z 50
n gf n
PSMB9
RH 24 0.48 19
RR 22 0.44 23
HH 4 0.08 8
PSMB8
KQ 29 0.58 8
QQ 12 0.24 36
KK 9 0.18 6
HP: hypersensitivity pneumonitis; EAS: exposed asymptomatic subjectfragmentswere electrophoresed in a 3% agarose 1000 gel and
visualized by ethidium bromide staining.
Statistical analysis
Allele and genotype frequencies of PSMB9 and PSMB8 were
determined by direct counting in both study groups. Asso-
ciation between specific PSMB9 and PSMB8 was assessed by
Fisher’s Exact Tests at conventional significance levels
(<0.05) and odds ratios (OR) and their corresponding 95%
confidence intervals (CI), using Epi Info 6 v 6.04d statistical
program (Stone Mountain, GA). Association analysis was
done at allele, genotype and haplotype level.
Results
Allele and genotype frequencies
We analyzed PSMB9 and PSMB8 polymorphisms in 50 HP
patients and 50 bird-exposed but asymptomatic individuals
by using RFLP. This strategy was preferred instead of the
hybridization with Sequence Specific Oligonucleotides (SSO)
and Sequence Specific Primers (SSP) because it is a potent
tool to detect polymorphisms and make false positive
results very unlikely. Also, false negative data are avoided
and the homozygosity of the sample tested is unequivocally
established.
The allele frequencies (af) of the PSMB9 and PSMB8 genes
in the amino acid position 60 and 49, respectively are shownp Value OR (CI 95%)
gf
0.38 0.419 1.51 (0.63e3.61)
0.46 1.0 0.92 (0.39e2.18)
0.16 0.355 0.46 (0.09e1.87)
0.16 0.000034 7.25 (2.61e21.3)
0.72 0.000004 0.12 (0.05e0.33)
0.12 0.575 1.61 (0.46e5.98)
s; OR: Odds ratio, CI: confidence interval, gf: genotype frequency.
Table 4 Haplotype frequencies of PSMB9-PSMB8.
Haplotype
PSMB9-PSMB8
HP patients
n Z 50
EAS group
n Z 50
p Value OR
(CI 95%)
n hf n hf
RH-KQ 11 0.22 2 0.04 0.0173 6.77 (1.34e65.31)
RR-KQ 10 0.20 6 0.12 0.4139 1.83 (0.54e6.69)
RR-QQ 8 0.16 13 0.26 0.3260 0.54 (0.18e1.61)
HH-KQ 8 0.16 0 0.00 0.0160 0.03 (1.15e422.39)
RR-KK 5 0.10 3 0.06 0.7149 1.74 (0.32e11.80)
RH-QQ 4 0.08 19 0.38 0.0008 0.14 (0.03e0.49)
RH-KK 4 0.08 3 0.06 1.0 1.36 (0.22e9.79)
HH-QQ 0 0.00 4 0.08 0.3621 0.23 (0.00e2.52)
HP: hypersensitivity pneumonitis; EAS: exposed asymptomatic subjects; OR: Odds ratio, CI: confidence interval, hf: haplotype frequency.
892 A´. Camarena et al.in Table 2. Regarding PSMB8, the K (Lys) allele was signifi-
cantly increased in the HP group with an allele frequency of
0.47 versus 0.20 in the EAS group (ORZ 3.55; 95% CIZ 1.82e
7.03; p < 0.0001). Accordingly, the frequency of the Q (Gln)
allele was decreased in the HP patients. In contrast, allele
analysis of PSMB9 did not reveal significant differences
among patients and control subjects.
The evaluation of the genotypes showed a significant
increase of the heterozygous KQ genotype in HP in
comparison with EAS controls (ORZ 7.25 95% CIZ 0.2.61e
21.3; p < 0.000034) (Table 3). Likewise, the frequency of
the genotype QQ was considerably lower in HP group
(OR Z 0.12 95% CI Z 0.05e0.33). Regarding PSMB9, RH
heterozygous was the most common genotype in HP
patients (gfZ 0.48), while RR homozygous prevailed in EAS
group (gf Z 0.46). However, no associations were found
between patients and exposed healthy subjects. All geno-
types were under HardyeWeinberg Equilibrium (HWE).
Haplotype analysis
Haplotype frequencies are presented in Table 4. A total of
seven haplotypes PSMB9-PSMB8 were detected in both
groups. The HH-QQ combination was present only in the EAS
group while HH-KQ was found only in the HP patients group.
In the EAS, two haplotypes gather 64% of combinations (RH-
QQ Z 38% and RR-QQ Z 26%). The distribution in HP
patients was heterogeneous but two haplotypes reach 42%
of combinations (RH-KQ Z 22% and RR-KQ Z 20%). The
haplotype RH-KQ was significantly increased in the HP
group when compared to EAS controls (OR Z 6.77, 95%
CI Z 1.34e65.31; p < 0.02). Likewise, HP patients dis-
played a decreased frequency of haplotype RH-QQ
(p < 0.001, OR Z 0.14 95% CI Z 0.03e0.49).
Discussion
We have previously found that genetic susceptibility asso-
ciated to MHC class II as well as to variants of the TAP
genes5 are implicated in the risk to develop the disease.4,5
In the present study we found that polymorphisms of the
PSMB8 gene appear also to be involved.
Proteasomes aredistributed throughout eukaryotic cells at
a high concentration and cleave foreign peptides in an ATP/
ubiquitin-dependent process in a non-lysosomal pathway. ThePSMB9 and PSMB8 coding genes are located within the class II
region, and participate in the antigen processing.8e10 In this
context, putative associations between PSMB genes and
a large variety of autoimmune,16e19 infectious20,21 and
inflammatory diseases22 have been reported.
In this study, we explored the distribution of poly-
morphisms in the PSMB9 and PSMB8 genes corresponding to
amino acid positions 60 and 49 respectively, in patients
with hypersensitivity pneumonitis and exposed but asymp-
tomatic Mexican Mestizo subjects. Our results revealed
a significant increase of K allele and KQ genotype of PSMB8
gene, as well as the haplotype RH-KQ in the HP patients.
Although the functional relevance of these SNPs in HP is yet
unclear, the strong associations point to either direct gene
or near loci to influence HP. HLA-independent effects of
PSMB gene polymorphisms have been associated to other
diseases like diabetes mellitus.19
There are no studies determining whether the products
of different PSMB alleles differ with respect to the peptides
produced.23 However, these subunits may directly affect
peptide cleavage specificity which may be important to
determine susceptibility in immunopathological disorders
such as hypersensitivity pneumonitis.22 Some evidence
emerges from mice models, where preliminary findings
suggest that structural polymorphism in LMP2 (Arg60His)
may have functional implications.24 Interestingly, a single
amino acid change at position 272 from glycine to arginine
significantly affects its migration on SDS-PAGE gels. More-
over, in mutant mice a target deletion of the LMP gene
resulted in the decreased expression of MHC class I mole-
cules on cell surface, which leads to inefficient endogenous
antigen presentation.25
It has been demonstrated that proteasomes containing
LMP7 (PSMB8) play an indispensable role in the survival of
mice infected with Toxoplasma gondii, presumably due to
the efficient generation of cytotoxic T lymphocytes
epitopes required for the functional development of
CD8(þ) T-cells.21 Activation of cytotoxic T-cells play
a relevant role in the pathogenesis of HP and requires
presentation of endogenous antigenic peptides by MHC
class I molecules. In this context, it is currently accepted
that an exaggerated cell-mediated immune response
contributes to the development of HP.26
Interestingly, it was recently reported that a selective
inhibitor of PSMB8 (PR-957) blocks LMP7-specific
Table 5 Alleles frequencies in our study (control group) and data of others populations.
Population Polymorphisms PSMB9
(LMP2) rs17587
Polymorphisms PSMB8
(LMP7) rs2071543
Reference
n R(Arg) H(His) n Q(Gln) K(Lys)
ASW 106 0.764 0.236 106 0.887 0.113 30
CEU 226 0.748 0.252 226 0.832 0.168 30
CHB 168 0.845 0.155 168 0.839 0.161 30
GUA 184 0.989 0.011 93 0.873 0.127 23
JPN 172 0.802 0.198 172 0.837 0.163 30
KAI 478 0.805 0.195 241 0.485 0.515 23
MAZ 112 0.767 0.232 52 0.942 0.058 31
MAY 126 0.650 0.350 126 0.873 0.127 31
MEX 100 0.800 0.200 100 0.770 0.230 30
MEXM 190 0.731 0.268 190 0.894 0.106 31
MEXMO 50 0.650 0.350 50 0.800 0.200 Our study
NAH 96 0.656 0.343 96 0.916 0.084 31
SPA 204 0.784 0.216 102 0.883 0.117 32
TEN 100 0.720 0.280 100 0.910 0.090 31
Population description: ASW: African ancestry in southwest USA, CEU: Utah residents with Northern and Western European ancestry
from the CEPH collection, CHB: Chinese in Beijing, GUA: Guarani (Brazil), JPN: Japanese in Tokyo, KAI: Kaingang (Brazil), MAZ:
Mazatecans (Mexico), MAY: Mayos (Mexico), MEX: Mexican ancestry in los Angeles, California, MEXM: Mexican Mestizos in Mexico City,
MEXMO: Mexican Mestizos in our study (control subjects), NAH: Nahuas (Mexico), SPA: Spain, TEN: Teenek (Mexico).
PSMB polymorphisms and HP 893presentation in MHC class I restricts antigens in vitro and
in vivo.27 As a consequence, this inhibition prevents the
production of interleukin-23 (IL-23) by activated monocytes
and interferon-g and IL-2 by T lymphocytes. In mice rheu-
matoid arthritis models, PR-957 treatment reversed signs of
disease and resulted in reductions of cellular infiltration,
cytokine production and autoantibody levels. These studies
reveal a unique role for LMP7 in controlling pathogenic
immune responses and provide a therapeutic rationale for
targeting LMP7 in autoimmune disorders.27
Finally, we have reviewed the alleles frequencies of these
SNPs in different populations (Table 5): African, Amerindians
of Brazil and Mexico, Asian, Caucasians, Hispanic (Spain)
Mexican ancestry from Los Angeles people, Mexican Mestizo
populations and the data obtained in our study, andwe found
that PSMB8 alleles and genotype frequencies are similar
among populations with the exception of native Amerindian
groups where low frequency of PSMB8 K alleles are observed,
while the Kaingang population (Brazil) showed a high
frequency of this allele. This result suggest that this allele
was absent in humans from northern Asia who settled in the
Artic and populated the Americas more than 25,000 years
before and that it has been acquired more recently by
genetic admixture.28 Regarding to PSMB9 gene we observed
differences between the analyzed groups, displaying
heterogeneity in their distribution particularly when
comparing with the Amerindian population. Some genetic
populations studies support the notion that distribution of
PSMB and TAP alleles in people living in developed countries
may differ from that seen in people living in developing ones
due to pathogen driving selection pressures.29 These findings
suggest that the differences in frequencies of PSMB9 geno-
type could be helpful in distinguishing each of these
populations.
In summary, the results of this study suggest that there is
an association between some genotype of the PSMB genes
and hypersensitivity pneumonitis in Mexican population.Particularly PSMB8 KQ genotype may play a role in the
development of HP while PSMB8 QQ might play a protective
role. Additional studies in a large cohort of patients and
functional analyses of individual SNPs could help to estab-
lish the real significance and deleterious effects of these
variations located in the coding region of LMP gene in the
susceptibility to HP.Conflict of interest statement
The authors have no conflicts of interest to declare.
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